Live Markets
Wednesday, July 29, 2026·George Town, KY·29°·Partly Cloudy
Markets Open · NYSE·Newsletter·Masthead·
VOL. XII · NO. 117Established MMXIV · George Town, Grand CaymanAtlantic Edition · $4.50

The Cayman Journal

Finance · Business · Technology · Caribbean & Global Affairs
Markets

Profusa, Inc. (NVACW)

NCM

$0.11-0.01 (-8.33%)Quote refreshed

Sources: Yahoo Finance (quote, statistics) · SEC EDGAR (filings, insider trades, 13F holders) · company filings & press wires

Market Cap
P/E (TTM)
EPS
Div Yield
52W Range
$0.10–$0.12
Beta
0.44

Company overview

Profusa, Inc., a digital health technology company, develops bioengineered sensors for body to detect and continuously transmit clinical-grade data for personal and medical use in the United States. It offers the Lumee Oxygen Platform to monitor compromised tissue for peripheral artery disease, chronic wounds, and reconstructive surgery. The company researches and develops the Lumee Glucose Platform which is designed to monitor glucose levels in interstitial fluid. Profusa, Inc. is based in Berkeley, California.

Peers in industry

Profusa, Inc. has no peer companies in this window.

Recent press releases

Profusa, Inc. has not issued a press release in this window.

SEC filings

All filings →

Profusa, Inc. has not filed an SEC document in this window.

Profusa, Inc. has no reported insider trades in the last 90 days.

Institutional holders

All holders →
As of 2025-12-31 · prior 2025-09-30
UBS Group AG$371,950
3,542,380 sh+5203.8%
422,574 sh0.0%
149,092 sh0.0%
157,245 sh+8.9%
86,916 sh+410.6%
29,300 sh● NEW
15,000 sh0.0%

People at Profusa, Inc.

All people →

No officers or directors have been indexed for Profusa, Inc..

Quarterly financials

Full financials →
Revenue trend
03/25
NI -$1.1M
06/25
NI -$8.2M
09/25
$75.0K
NI -$22.2M
RevenueNI = Net Income
EPS trend (diluted)
Latest: $-0.70
Prior: $-1.53
Revenue sparkline
Profusa, Inc. (NVACW) Stock Quote, Press Releas... | Cayman Journal | Cayman Journal